Champions Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSBR and other ETFs, options, and stocks.About CSBR
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.
CEORobert Brainin
CEORobert Brainin
Employees213
Employees213
HeadquartersHackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded1985
Founded1985
Employees213
Employees213
CSBR Key Statistics
Market cap89.90M
Market cap89.90M
Price-Earnings ratio33.88
Price-Earnings ratio33.88
Dividend yield—
Dividend yield—
Average volume9.86K
Average volume9.86K
High today$6.63
High today$6.63
Low today$6.50
Low today$6.50
Open price$6.58
Open price$6.58
Volume6.72K
Volume6.72K
52 Week high$11.99
52 Week high$11.99
52 Week low$4.07
52 Week low$4.07
Stock Snapshot
With a market cap of 89.9M, Champions Oncology(CSBR) trades at $6.52. The stock has a price-to-earnings ratio of 33.88.
On 2025-11-24, Champions Oncology(CSBR) stock traded between a low of $6.50 and a high of $6.63. Shares are currently priced at $6.52, which is +0.3% above the low and -1.7% below the high.
Champions Oncology(CSBR) shares are trading with a volume of 6.72K, against a daily average of 9.86K.
In the last year, Champions Oncology(CSBR) shares hit a 52-week high of $11.99 and a 52-week low of $4.07.
In the last year, Champions Oncology(CSBR) shares hit a 52-week high of $11.99 and a 52-week low of $4.07.
People also own
Based on the portfolios of people who own CSBR. This list is generated using Robinhood data, and it’s not a recommendation.